[Form 3] Jaguar Health, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Lincoln Alternative Strategies LLC filed a Form 3 reporting initial beneficial ownership in Jaguar Health, Inc. (JAGX). The filing states the reporting person holds 600,000 shares of Common Stock as a direct owner. The filing identifies the reporting persons relationship to the issuer as a Director and 10% owner. The statement is dated 08/28/2025 with a signature dated 08/29/2025.

Insights

Financial Analyst

TL;DR: A new disclosure shows a director-level entity directly holds 600,000 JAGX shares, a routine Section 16 filing.

The Form 3 reports initial beneficial ownership of 600,000 common shares held directly by Lincoln Alternative Strategies LLC and identifies a director and 10% owner relationship. This is a standard initial disclosure under Section 16; the filing does not include transaction prices, acquisition dates, or derivative positions. No earnings or financing details are disclosed.

Corporate Governance Expert

TL;DR: Governance disclosure complete for initial beneficial owner; no additional governance actions or changes are reported.

The filing fulfills the requirement to report a director-affiliated reporting persons initial direct ownership of 600,000 common shares. It contains no amendments, no derivative holdings, and no explanatory notes about voting agreements or control. As presented, the document is a routine ownership disclosure without material corporate-governance events.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lincoln Alternative Strategies LLC

(Last) (First) (Middle)

404 WASHINGTON AVE., SUITE 650

(Street)

MIAMI BEACH FL 33139

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/28/2025

3. Issuer Name and Ticker or Trading Symbol
Jaguar Health, Inc. [ JAGX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	600,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Stephen Temes	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lincoln Alternative Strategies LLC report on Form 3 for JAGX?

The filer reported direct ownership of 600,000 shares of Jaguar Health, Inc. common stock and identified the relationship as a Director and 10% owner.

Does the Form 3 report any derivative securities for JAGX?

No. Table II for derivative securities is blank; the filing reports only non-derivative common stock ownership.

What are the relevant dates on the Form 3 filing for JAGX?

The event requiring the statement is dated 08/28/2025 and the filing bears a signature date of 08/29/2025.

Is the ownership reported as direct or indirect on the Form 3?

The filing states the 600,000 shares are held directly (D) by the reporting person.

Does the filing disclose purchase price or acquisition date for the shares?

No. The Form 3 does not provide any purchase price or specific acquisition date information.